Democratic Republic of the Congo
4 Vaccines Approved for Use in Democratic Republic of the Congo
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Approval Source: actualite.cd
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: actualite.cd
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Approval Source: aa.com.tr
2 in Clinical Trials in Democratic Republic of the Congo
Protein Subunit
Novavax
Nuvaxovid
Approved in 37 countries
16 trials in 12 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries